Collegium Pharmaceutical, Inc. COLL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $252.16M+161% | $96.61M-59.6% | $238.95M+37.6% | $173.69M-6.8% | ||
| $155.43M+68.6% | $92.2M+28.8% | $71.6M— | $0— | ||
| $211.33M-7.5% | $228.54M+27.3% | $179.53M-2.0% | $183.12M+73.0% | ||
| $14.01M-60.6% | $35.56M+10.0% | $32.33M-30.5% | $46.5M+167% | ||
| $691.41M+43.4% | $482.26M-10.3% | $537.6M+28.0% | $419.99M+33.1% | ||
| $12.01M-16.2% | $14.33M-10.3% | $15.98M-18.1% | $19.52M+0.2% | ||
| $145.93M-10.1% | $162.33M+21.3% | $133.86M+0.1% | $133.7M-50.2% | ||
| $669.51M-24.9% | $891.4M+111% | $421.71M-25.7% | $567.47M+111% | ||
| $1.66B-0.4% | $1.66B+45.5% | $1.14B-2.6% | $1.17B+69.7% | ||
| $10.66M+171% | $3.93M-54.7% | $8.69M+149% | $3.49M-16.6% | ||
| $667K— | $0— | —— | —— | ||
| $440.03M-13.6% | $509.51M+11.3% | $457.92M+5.6% | $433.73M+55.1% | ||
| $1.36B-5.5% | $1.43B+51.4% | $947.88M-3.2% | $979.29M+100% | ||
| 100M+249,900% | 40K+5.3% | 38K+2.7% | 37K+2.8% | ||
| -$101.13M+38.3% | -$164M+29.7% | -$233.19M+17.1% | -$281.34M-9.8% | ||
| $301.68M+31.8% | $228.84M+17.1% | $195.43M+0.3% | $194.84M-4.0% | ||
| $1.66B-0.4% | $1.66B+45.5% | $1.14B-2.6% | $1.17B+69.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Collegium Pharmaceutical, Inc.'s total assets?
- Collegium Pharmaceutical, Inc. (COLL) holds $1.7B in total assets, up 1.3% year over year.
- How much debt does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. carries $5.2M in total debt against $312.4M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. holds $289.6M in cash and equivalents.
- Can Collegium Pharmaceutical, Inc. cover its short-term obligations?
- Its current ratio is 1.71 — current assets exceed current liabilities.
- Where does Collegium Pharmaceutical, Inc.'s balance sheet data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
